Bruce Gomes

1.6k total citations
17 papers, 1.3k citations indexed

About

Bruce Gomes is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bruce Gomes has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Bruce Gomes's work include Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Bruce Gomes is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Bruce Gomes collaborates with scholars based in United States, United Kingdom and China. Bruce Gomes's co-authors include Gary Kasof, Anne M. Strimpler, Matthew V. Lorenzi, Derong Liu, Paul A. Tuthill, Philip D. Edwards, Gabriel Helmlinger, Joseph C. Williams, Gabriele Fendrich and Edgar F. Meyer and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Bruce Gomes

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Gomes United States 16 834 267 261 226 173 17 1.3k
A.G. Pavlovsky United States 23 827 1.0× 359 1.3× 232 0.9× 156 0.7× 340 2.0× 37 1.5k
Kenneth M. Comess United States 16 756 0.9× 279 1.0× 189 0.7× 171 0.8× 124 0.7× 17 1.2k
J A Double United Kingdom 15 821 1.0× 523 2.0× 191 0.7× 185 0.8× 374 2.2× 29 1.7k
Hans R. Hendriks Netherlands 21 580 0.7× 321 1.2× 186 0.7× 259 1.1× 252 1.5× 49 1.3k
Richard A. Norman United Kingdom 18 1.0k 1.2× 269 1.0× 325 1.2× 76 0.3× 145 0.8× 26 1.5k
Rashid Syed United States 14 724 0.9× 198 0.7× 143 0.5× 212 0.9× 258 1.5× 15 1.5k
Benjamin R. Bowen United States 18 875 1.0× 112 0.4× 239 0.9× 157 0.7× 210 1.2× 25 1.2k
Frank Bennett United States 23 1.2k 1.4× 272 1.0× 397 1.5× 251 1.1× 93 0.5× 75 2.0k
Taoufik Ouatas United States 23 866 1.0× 337 1.3× 89 0.3× 183 0.8× 185 1.1× 38 1.8k
Manchao Zhang United States 17 861 1.0× 321 1.2× 165 0.6× 146 0.6× 240 1.4× 60 1.3k

Countries citing papers authored by Bruce Gomes

Since Specialization
Citations

This map shows the geographic impact of Bruce Gomes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Gomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Gomes more than expected).

Fields of papers citing papers by Bruce Gomes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Gomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Gomes. The network helps show where Bruce Gomes may publish in the future.

Co-authorship network of co-authors of Bruce Gomes

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Gomes. A scholar is included among the top collaborators of Bruce Gomes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Gomes. Bruce Gomes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ji, Yan, Deborah Knee, Lore Gruenbaum, et al.. (2023). Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment. CPT Pharmacometrics & Systems Pharmacology. 12(3). 413–424. 8 indexed citations
2.
Helmlinger, Gabriel, et al.. (2015). A Mechanistic Tumor Penetration Model to Guide Antibody Drug Conjugate Design. PLoS ONE. 10(3). e0118977–e0118977. 72 indexed citations
3.
Chaparro‐Riggers, Javier, Liang Hong, Rachel M. DeVay, et al.. (2012). Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9. Journal of Biological Chemistry. 287(14). 11090–11097. 137 indexed citations
4.
Kasof, Gary & Bruce Gomes. (2001). Livin, a Novel Inhibitor of Apoptosis Protein Family Member. Journal of Biological Chemistry. 276(5). 3238–3246. 371 indexed citations
5.
Kasof, Gary, et al.. (2001). Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB. Oncogene. 20(55). 7965–7975. 79 indexed citations
6.
Kasof, Gary, et al.. (2000). The RIP‐like kinase, RIP3, induces apoptosis and NF‐κB nuclear translocation and localizes to mitochondria. FEBS Letters. 473(3). 285–291. 97 indexed citations
7.
Edwards, Philip D., Donald W. Andisik, Bruce Gomes, et al.. (1997). Discovery and Biological Activity of Orally Active Peptidyl Trifluoromethyl Ketone Inhibitors of Human Neutrophil Elastase. Journal of Medicinal Chemistry. 40(12). 1876–1885. 39 indexed citations
8.
Edwards, Philip D., Donald W. Andisik, Anne M. Strimpler, Bruce Gomes, & Paul A. Tuthill. (1996). Nonpeptidic Inhibitors of Human Neutrophil Elastase. 7. Design, Synthesis, and in Vitro Activity of a Series of Pyridopyrimidine Trifluoromethyl Ketones. Journal of Medicinal Chemistry. 39(5). 1112–1124. 32 indexed citations
10.
Bernstein, Peter R, et al.. (1995). Nonpeptidic Inhibitors of Human Leukocyte Elastase. 6. Design of a Potent, Intratracheally Active, Pyridone-Based Trifluoromethyl Ketone. Journal of Medicinal Chemistry. 38(1). 212–215. 37 indexed citations
12.
Damewood, James, Philip D. Edwards, Bruce Gomes, et al.. (1994). Nonpeptidic Inhibitors of Human Leukocyte Elastase. 2. Design, Synthesis, and in vitro Activity of a Series of 3-Amino-6-aryl-2-oxopyridyl Trifluoromethyl Ketones. Journal of Medicinal Chemistry. 37(20). 3303–3312. 25 indexed citations
13.
Warner, Peter, et al.. (1994). Non-peptidic Inhibitors of Human Leukocyte Elastase. 1. The Design and Synthesis of Pyridone-Containing Inhibitors. Journal of Medicinal Chemistry. 37(19). 3090–3099. 36 indexed citations
14.
Wasserman, Harry H., et al.. (1993). Synthesis and evaluation of peptidyl vicinal tricarbonyl monohydrates as inhibitors of hydrolytic enzymes. The Journal of Organic Chemistry. 58(18). 4785–4787. 46 indexed citations
16.
Sommerhoff, Christian P., et al.. (1991). Inhibition of human neutrophil elastase by ICI 200,355. European Journal of Pharmacology. 193(2). 153–158. 32 indexed citations
17.
Gomes, Bruce, Gabriele Fendrich, & Robert H. Abeles. (1981). Mechanism of action of glutaryl-CoA and butyryl-CoA dehydrogenases. Purification of glutaryl-CoA dehydrogenase. Biochemistry. 20(6). 1481–1490. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026